Challenging Issues in Clinical Trial Design
نویسندگان
چکیده
منابع مشابه
Statistical issues in clinical trial design.
This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.
متن کاملChallenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials.
As a sequel to last week's paper on the fundamentals of clinical trial design, this paper tackles related controversial issues: noninferiority trials, the value of factorial designs, the importance and challenges of strategy trials, Data Monitoring Committees (including when to stop a trial early), and the role of adaptive designs. All topics are illustrated by relevant examples from cardiology...
متن کاملCurrent issues in clinical trial design: superiority versus equivalency studies.
HISTORICALLY, the gold standard for drug approval by positive for the human immunodeficiency virus were the US Food and Drug Administration (FDA) has been randomized to the placebo group at a time when it was convincing evidence of efficacy in double-blind, placeknown that azidothymidine (AZT) prevented fetal trans bo-controlled, clinical trials. Because a placebo-conmission of the virus. On Fe...
متن کاملTargeting targeted agents: open issues for clinical trial design
Molecularly targeted agents for the treatment of solid tumors had entered the market in the last 5 years, with a great impact upon both the scientific community and the society. Many randomized phase III trials conducted in recent years with new targeted agents, despite previous data coming from preclinical research and from phase II trials were often promising, have produced disappointingly ne...
متن کاملCurrent Therapeutic Cannabis Controversies and Clinical Trial Design Issues
This overview covers a wide range of cannabis topics, initially examining issues in dispensaries and self-administration, plus regulatory requirements for production of cannabis-based medicines, particularly the Food and Drug Administration "Botanical Guidance." The remainder pertains to various cannabis controversies that certainly require closer examination if the scientific, consumer, and go...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2015
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2015.10.051